Chemical Found In Ayahuasca May Be Able To Completely Reverse Diabetes

Diabetes currently affects hundreds of millions of people worldwide. In America alone, the Centers for Disease Control and Prevention (CDC) estimates that number to be approximately 20 million. Potential cures and methods to reverse the disease are showing some promising results, and one of them is a chemical that’s commonly found in a number of plants around the world. It’s also a main ingredient in the psychoactive mixture commonly known as ayahuasca.
Diabetes is an autoimmune disease that prevents a person’s pancreas from producing insulin, which is a hormone that enables people to receive energy from their food. This occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, which are called beta cells. Apparently, the cause is not well understood, but scientists believe that genetic and environmental factors play a role. Modern day mainstream science tells us that there are no cures.
Again, types 1 and 2 diabetes affect some 380 million people worldwide. Both ultimately result from a deficiency of functional pancreatic insulin-producing beta cells, which is where this chemical is showing the most promising results.
New research published in the journal Nature Medicine – a study led by researchers at the Icahn School of Medicine at Mount Sinai, funded by JDRF and the National Institutes of Health – found that:
“Using three different mouse and human islet in vivo–based models, we show that harmine is able to induce beta cell proliferation, increase islet mass and improve glycemic control. These observations sugg Continue reading

Rate this article

Total 1 ratings

MGH Researcher’s Diabetes Quest Takes Big Step

The FDA approves the second phase of Dr. Denise Faustman’s clinical testing of a type 1 diabetes vaccine, an exciting next step in her pursuit of a therapy to reverse the disease.
After nearly 20 years of research, Massachusetts General Hospital researcher Denise Faustman, MD, PhD, has made a promising advance in her quest to cure type 1 diabetes.
Her team recently passed a major threshold by receiving FDA clearance to test a large group of long-term diabetics with an old tuberculosis vaccine that could also combat type 1 diabetes. The phase 2 trial of the bacillus Calmette-Guérin (BCG) vaccine was announced last month at an American Diabetes Association conference in Boston, an exciting next step in Dr. Faustman’s pursuit of a therapy to reverse the disease.
“We’re in full action mode. The phones are ringing off the hook.”
While thrilled about receiving the FDA’s blessing, Dr. Faustman and her staff didn’t celebrate for long. They’re already accepting applications for patients who want to participate in the five-year trial that starts this summer.
We’re in full action mode. The phones are ringing off the hook,” Dr. Faustman says. As many as 100,000 diabetics are expected to volunteer for the clinical trial, but the MGH Immunobiology Laboratory will winnow the number of participants to 150 adults, with some receiving BCG and others taking a placebo.
Old Vaccine, New Promise
The FDA approved the phase 2 trial essentially by certifying MGH’s use of BCG that will be produced by the Japanese government. Academics usually don’t have to look around the wo Continue reading

Research Shows This One Plant Can Kill Cancer Cells & Treat Diabetes

Bitter melon is a fruit that grows abundantly in Asia, Africa and the Caribbean. Traditionally it has been used to treat diabetes and other more mild diseases or illnesses.
More recently, bitter melon juice was shown to kill pancreatic cancer cells in vitro and in mice in a study done by the University of Colorado. Considering the results were seen in both in vitro and in vivo tests, the effectiveness of bitter melon juice in treating pancreatic cancer, and potentially other cancers, at a clinical level are promising.[1]
“IHC analyses of MiaPaCa-2 xenografts showed that BMJ(Bitter Melon Juice) also inhibits proliferation, induces apoptosis and activates AMPK (adenosine monophosphate-activated protein kinase) in vivo. Overall, BMJ exerts strong anticancer efficacy against human pancreatic carcinoma cells, both in vitro and in vivo, suggesting its clinical usefulness.”
Pancreatic cancer is one of the most difficult cancers to treat due to the fact that it is often discovered late, leaving very little time to treat. Since traditional therapies (chemotherapy, radiation, surgery etc) were not showing promising results and littler advancement was being made, researchers have been looking elsewhere to find treatment.
Interestingly, cannabis, specifically cannabinoids, have been shown to induce apoptic (programmed) death of human pancreatic cancer cells in vitro and stop pancreatic tumor growth in vivo.[4] Cannabis is perhaps one of the most popular treatments being aggressively pursued right now given its promising results both in labs and anecdotally.
Scientific Evidence
Panc Continue reading

Alabamian with diabetes built her own artificial pancreas, gives away plan for free

Dana Lewis is a good name to remember the next time you hear somebody say Alabama's mostly good for football and barbecue.
Lewis, a University of Alabama graduate who grew up in Huntsville, used social media, computer skills and mail-order parts to invent an artificial pancreas for people with diabetes. Along with co-inventor and husband Scott Leibrand, she's now giving her discovery away.
The device is a success - hundreds of people are using it, including Lewis - and it is bringing the young inventors increasing attention. Just this spring, Fast Company put the 28-year-old Lewis on its 2017 list of America's 100 "most creative people in business."
Diabetes is caused when the pancreas fails to make the insulin that helps the body turn glucose from sugar and carbohydrates into energy. Without insulin, sugar builds up in the blood stream. With too much insulin, it can fall to dangerously low levels. For diabetics, staying in the safe center is a constant challenge.
"You really do make hundreds of decisions a day about things that impact your blood sugar," Lewis said last week from her current home in Seattle. "It's a lot. And it really does impact everybody who cares for a person with diabetes - spouses, siblings, parents, grandparents. Oftentimes, a person with diabetes is surrounded by a half-a-dozen people who help care for them and love them."
Lewis was an example of that. She moved to Seattle for a job after graduating from Alabama. The daughter of a Huntsville engineer, she attended Grissom High School before going to Tuscaloosa.
At the university, Lewis minored in an Continue reading

A Fasting Diet Could Reverse Diabetes And Repair The Pancreas, Says New Research

Researchers have been able to reverse symptoms of diabetes and restore pancreas functions in mice by putting them on a version of the fasting-mimicking diet.
The diet tricks the body into a fasting mode for a few days a month, even while carefully selected foods are still being eaten, and it could be enough to reboot the organ's key functions and restore insulin production, scientists say.
Diabetes occurs when the pancreas cannot make insulin (type I) or is damaged by insulin resistance (type II), and the team from the University of Southern California says the diet reversed symptoms of both types of diabetes in mice.
"By pushing the mice into an extreme state and then bringing them back... the cells in the pancreas are triggered to use some kind of developmental reprogramming," says the head of the research team, Valter Longo.
In humans, the fasting-mimicking diet has been credited with helping people lose weight more effectively, and previous studies have also linked it to reducing risk factors for diseases like heart disease and cancer.
The diet has also been credited with reducing the symptoms of Multiple Sclerosis, so it's earning quite a reputation amongst scientists. In each case starving the body seems to reset the production of healthy cells.
In the latest study, mice were put into the artificial fasting mode for four days a week over a period of several months.
Scientists found this was enough to regenerate beta cells in the pancreas, responsible for storing and releasing insulin. Damaged cells were replaced by working ones.
The team also experimented on pancreati Continue reading